Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial
Karin Due Bruun, Robin Christensen, Kirstine Amris, Henrik Bjarke Vægter, Morten Rune Blichfeldt‐Eckhardt, Lars Bye-Møller, Anders Holsgaard‐Larsen, Palle Toft
Topics & Concepts
PlaceboDouble blindNaltrexoneFibromyalgiaMedicineAnesthesiaPhysical therapyInternal medicineOpioidAlternative medicineReceptorPathologyFibromyalgia and Chronic Fatigue Syndrome ResearchPsychosomatic Disorders and Their TreatmentsSubstance Abuse Treatment and Outcomes